Answers are grounded in this paper and cite their sources.
Our findings suggest that the inflammation in patients with APLAID is partially driven by activation of the NLRP3 inflammasome. These data link 2 seemingly distinct molecular pathways and provide new insights into the pathogenesis of APLAID and autoinflammation.
No takes yet. Share an insight, caveat, or question.
Chae et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: